等待开盘 12-20 09:30:00 美东时间
-0.440
-3.70%
今日重点评级关注:巴克莱:维持Iovance Biotherapeutics"超配"评级,目标价从9美元升至10美元;摩根大通:上调Recursion Pharmaceuticals评级至"超配",目标价从10美元升至11美元
12-18 10:54
BTIG analyst Nick Altmann initiates coverage on Amplitude (NASDAQ:AMPL) with a Buy rating and announces Price Target of $14.
12-17 18:58
高通、ARM、礼来、Snap、Robinhood等获多家大行上调目标价;Adient、DoorDash、多邻国、Figma、飞塔信息、HubSpot、康丽数码等遭大行下调目标价
11-07 10:14
Amplitude shares are trading higher after the company reported better-than-expe...
11-06 06:26
Companies Reporting Before The Bell • Avient (NYSE:AVNT) is estimated to report...
11-05 19:12
今日重点评级关注:康托·菲茨杰拉德:维持Cabaletta Bio"超配"评级,目标价从15美元升至30美元;HC Wainwright & Co.:维持Invivyd"买入"评级,目标价从5美元升至10美元
11-03 20:20
UBS analyst Taylor McGinnis upgrades Amplitude (NASDAQ:AMPL) from Neutral to Buy and maintains the price target from $13 to $13.
10-31 23:32
Amplify Energy announced the sale of its East Texas assets for $127.5 million, completing its exit from Haynesville and Cotton Valley interests. The proceeds will reduce debt, simplify operations, and focus on high-potential areas like Beta and Bairoil.
10-29 10:00
D.A. Davidson analyst Clark Wright reiterated a Buy rating on Amplitude today a...
09-30 00:55